Medicine Advanced While Patients Waited. Drug resistance and global health failures in the modern tuberculosis crisis

Tuberculosis never disappeared equally. While wealthy nations reduced infection rates through antibiotics and public health infrastructure, millions elsewhere continued facing overcrowded clinics, interrupted treatment, and preventable deaths. The disease survived wherever medicine remained unevenly distributed. This account investigates the political history of tuberculosis treatment from the discovery of effective antibiotics to the rise of Multi-Drug Resistant Tuberculosis.
Pharmaceutical patents, international funding disparities, and inconsistent healthcare systems repeatedly slowed global eradication efforts. Medical breakthroughs often arrived without the political commitment required to make them universally accessible. The book also traces the scientific evolution of the tuberculosis bacterium itself. From Robert Koch's laboratory discoveries to modern genomic research, scientists gradually understood how microbial mutation adapts to incomplete treatment and fragile healthcare networks.
Drug resistance therefore emerged not only from biology, but from economic inequality and policy failure. Tuberculosis becomes here a mirror of the global order: a disease shaped as much by trade systems, intellectual property law, and political priorities as by microbiology alone.